123 related articles for article (PubMed ID: 27873267)
21. Epstein-Barr virus: biology and disease.
Cruchley AT; Williams DM; Niedobitek G; Young LS
Oral Dis; 1997 May; 3 Suppl 1():S156-63. PubMed ID: 9456681
[TBL] [Abstract][Full Text] [Related]
22. Oropharyngeal malignant epithelial cell, lymphocyte and macrophage CD44 surface receptors for hyaluronate are expressed in sustained EBV infection: immunohistochemical data and EBV DNA tissue indices.
Groma V; Kazanceva A; Nora-Krukle Z; Murovska M
Pathol Res Pract; 2012 Sep; 208(9):518-26. PubMed ID: 22770970
[TBL] [Abstract][Full Text] [Related]
23. Roles of cell signaling pathways in cell-to-cell contact-mediated Epstein-Barr virus transmission.
Nanbo A; Terada H; Kachi K; Takada K; Matsuda T
J Virol; 2012 Sep; 86(17):9285-96. PubMed ID: 22718812
[TBL] [Abstract][Full Text] [Related]
24. Aberrant Epstein-Barr virus persistence in HIV carriers is characterized by anti-Epstein-Barr virus IgA and high cellular viral loads with restricted transcription.
Stevens SJ; Smits PH; Verkuijlen SA; Rockx DA; van Gorp EC; Mulder JW; Middeldorp JM
AIDS; 2007 Oct; 21(16):2141-9. PubMed ID: 18090040
[TBL] [Abstract][Full Text] [Related]
25. Epstein-Barr Virus Lytic Cycle Reactivation.
McKenzie J; El-Guindy A
Curr Top Microbiol Immunol; 2015; 391():237-61. PubMed ID: 26428377
[TBL] [Abstract][Full Text] [Related]
26. [The entry of Epstein-Barr virus into B lymphocytes and epithelial cells during infection].
Zuo LL; Zhu MJ; Du SJ; Lu JH; Li GY
Bing Du Xue Bao; 2014 Jul; 30(4):476-82. PubMed ID: 25272606
[TBL] [Abstract][Full Text] [Related]
27. Oral EBV and KSHV infection in HIV.
Webster-Cyriaque J; Duus K; Cooper C; Duncan M
Adv Dent Res; 2006 Apr; 19(1):91-5. PubMed ID: 16672557
[TBL] [Abstract][Full Text] [Related]
28. Ephrin receptor A2, the epithelial receptor for Epstein-Barr virus entry, is not available for efficient infection in human gastric organoids.
Wallaschek N; Reuter S; Silkenat S; Wolf K; Niklas C; Kayisoglu Ö; Aguilar C; Wiegering A; Germer CT; Kircher S; Rosenwald A; Shannon-Lowe C; Bartfeld S
PLoS Pathog; 2021 Feb; 17(2):e1009210. PubMed ID: 33596248
[TBL] [Abstract][Full Text] [Related]
29. Epstein-Barr virus infection in ex vivo tonsil epithelial cell cultures of asymptomatic carriers.
Pegtel DM; Middeldorp J; Thorley-Lawson DA
J Virol; 2004 Nov; 78(22):12613-24. PubMed ID: 15507648
[TBL] [Abstract][Full Text] [Related]
30. Quantification of Epstein-Barr virus load in peripheral blood of human immunodeficiency virus-infected patients using real-time PCR.
Dehee A; Asselot C; Piolot T; Jacomet C; Rozenbaum W; Vidaud M; Garbarg-Chenon A; Nicolas JC
J Med Virol; 2001 Nov; 65(3):543-52. PubMed ID: 11596092
[TBL] [Abstract][Full Text] [Related]
31. Epstein-Barr virus transcytosis through polarized oral epithelial cells.
Tugizov SM; Herrera R; Palefsky JM
J Virol; 2013 Jul; 87(14):8179-94. PubMed ID: 23698302
[TBL] [Abstract][Full Text] [Related]
32. Detection of lymphocytes productively infected with Epstein-Barr virus in non-neoplastic tonsils.
Ikeda T; Kobayashi R; Horiuchi M; Nagata Y; Hasegawa M; Mizuno F; Hirai K
J Gen Virol; 2000 May; 81(Pt 5):1211-6. PubMed ID: 10769062
[TBL] [Abstract][Full Text] [Related]
33. Serum Epstein-Barr virus (EBV) viral load can be a complementary sensitive test in primary Epstein-Barr virus infection.
Berth M; Vanheule G; Depuydt C; Benoy I
J Clin Virol; 2011 Feb; 50(2):184-5. PubMed ID: 21112811
[No Abstract] [Full Text] [Related]
34. Intracellular localization of the Epstein-Barr virus BFRF1 gene product in lymphoid cell lines and oral hairy leukoplakia lesions.
Farina A; Cardinali G; Santarelli R; Gonnella R; Webster-Cyriaque J; Bei R; Muraro R; Frati L; Angeloni A; Torrisi MR; Faggioni A
J Med Virol; 2004 Jan; 72(1):102-11. PubMed ID: 14635017
[TBL] [Abstract][Full Text] [Related]
35. Detection of specific lytic and latent transcripts can help to predict the status of Epstein-Barr virus infection in transplant recipients with high virus load.
Zawilinska B; Kosinska A; Lenart M; Kopec J; Piatkowska-Jakubas B; Skotnicki A; Kosz-Vnenchak M
Acta Biochim Pol; 2008; 55(4):693-9. PubMed ID: 19015775
[TBL] [Abstract][Full Text] [Related]
36. LMP1-Induced Sumoylation Influences the Maintenance of Epstein-Barr Virus Latency through KAP1.
Bentz GL; Moss CR; Whitehurst CB; Moody CA; Pagano JS
J Virol; 2015 Aug; 89(15):7465-77. PubMed ID: 25948750
[TBL] [Abstract][Full Text] [Related]
37. Highly Efficient CRISPR/Cas9-Mediated Cloning and Functional Characterization of Gastric Cancer-Derived Epstein-Barr Virus Strains.
Kanda T; Furuse Y; Oshitani H; Kiyono T
J Virol; 2016 May; 90(9):4383-93. PubMed ID: 26889033
[TBL] [Abstract][Full Text] [Related]
38. Epstein-Barr virus B95.8 produced in 293 cells shows marked tropism for differentiated primary epithelial cells and reveals interindividual variation in susceptibility to viral infection.
Feederle R; Neuhierl B; Bannert H; Geletneky K; Shannon-Lowe C; Delecluse HJ
Int J Cancer; 2007 Aug; 121(3):588-94. PubMed ID: 17417777
[TBL] [Abstract][Full Text] [Related]
39. Human B cells on their route to latent infection--early but transient expression of lytic genes of Epstein-Barr virus.
Kalla M; Hammerschmidt W
Eur J Cell Biol; 2012 Jan; 91(1):65-9. PubMed ID: 21450364
[TBL] [Abstract][Full Text] [Related]
40. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study.
Leong IT; Fernandes BJ; Mock D
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):184-93. PubMed ID: 11505266
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
